Literature DB >> 8856326

Beta 4 integrin and other Schwann cell markers in axonal neuropathy.

A Quattrini1, S Previtali, M L Feltri, N Canal, R Nemni, L Wrabetz.   

Abstract

Schwann cell gene expression is dynamically regulated after peripheral nerve injury and during regeneration. We hypothesized that the changes in protein expression described after rat peripheral nerve injury could be used to identify single Schwann cell-axon units in human axonal neuropathy. Therefore, we performed immuno-fluorescence staining on sections of injured rat sciatic nerves compared with sections of neuropathic human sural nerves. We chose the markers beta 4 integrin, P0 glycoprotein, and glial fibrillary acidic protein (GFAP) to characterize Schwann cells, and neurofilament-heavy (NF-H) to recognize axons. Normal rat or human myelin-forming units demonstrated a sharp ring of beta 4 staining at their outer surface, P0 staining in the myelin sheath, and NF-H staining in the axon. Acutely denervated rat units transited from broken rings of beta 4 and P0 staining, to diffuse beta 4 and absent P0 and NF-H staining. Chronically denervated rat Schwann cells re-expressed beta 4 more highly, but in a diffuse, non-polarized pattern. In contrast, regenerating units re-expressed beta 4, P0, and NF-H; beta 4 staining was polarized to the outer surface of Schwann cells. Finally, GFAP staining increased progressively after injury and decreased during regeneration in the distal nerve stump. In neuropathic human sural nerves, we identified units exhibiting each of these beta 4, P0, and NF-H staining patterns; the proportion of each pattern correlated best with the extent and chronicity of axonal injury. Thus, synchronous injury of rat sciatic nerve predicts patterns of Schwann cell marker expression in human axonal neuropathy. In addition, the unique changes in the polarity of beta 4 integrin expression, in combination with changes in P0 and NF-H expression, may distinguish normal from denervated or reinnervated myelin-forming Schwann cells in human sural nerve biopsies.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8856326     DOI: 10.1002/(SICI)1098-1136(199608)17:4<294::AID-GLIA4>3.0.CO;2-#

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  38 in total

1.  Prostaglandin D2 synthase/GPR44: a signaling axis in PNS myelination.

Authors:  Amelia Trimarco; Maria Grazia Forese; Valentina Alfieri; Alessandra Lucente; Paola Brambilla; Giorgia Dina; Damiana Pieragostino; Paolo Sacchetta; Yoshihiro Urade; Brigitte Boizet-Bonhoure; Filippo Martinelli Boneschi; Angelo Quattrini; Carla Taveggia
Journal:  Nat Neurosci       Date:  2014-11-02       Impact factor: 24.884

2.  A dual role for Integrin α6β4 in modulating hereditary neuropathy with liability to pressure palsies.

Authors:  Yannick Poitelon; Vittoria Matafora; Nicholas Silvestri; Desirée Zambroni; Claire McGarry; Nora Serghany; Thomas Rush; Domenica Vizzuso; Felipe A Court; Angela Bachi; Lawrence Wrabetz; Maria Laura Feltri
Journal:  J Neurochem       Date:  2018-02-13       Impact factor: 5.372

3.  Mitochondrial biogenesis and fission in axons in cell culture and animal models of diabetic neuropathy.

Authors:  Andrea M Vincent; James L Edwards; Lisa L McLean; Yu Hong; Federica Cerri; Ignazio Lopez; Angelo Quattrini; Eva L Feldman
Journal:  Acta Neuropathol       Date:  2010-05-15       Impact factor: 17.088

4.  Neuregulin 1 type III improves peripheral nerve myelination in a mouse model of congenital hypomyelinating neuropathy.

Authors:  Sophie Belin; Francesca Ornaghi; Ghjuvan'Ghjacumu Shackleford; Jie Wang; Cristina Scapin; Camila Lopez-Anido; Nicholas Silvestri; Neil Robertson; Courtney Williamson; Akihiro Ishii; Carla Taveggia; John Svaren; Rashmi Bansal; Markus H Schwab; Klaus Nave; Pietro Fratta; Maurizio D'Antonio; Yannick Poitelon; M Laura Feltri; Lawrence Wrabetz
Journal:  Hum Mol Genet       Date:  2019-04-15       Impact factor: 6.150

Review 5.  Integrin beta 4 in neural cells.

Authors:  Le Su; Xin Lv; Junying Miao
Journal:  Neuromolecular Med       Date:  2008-05-31       Impact factor: 3.843

6.  Peripheral neuropathies: Biomarkers for axonal damage in immune-mediated neuropathy.

Authors:  Bart C Jacobs; Hugh J Willison
Journal:  Nat Rev Neurol       Date:  2009-11       Impact factor: 42.937

7.  Deletion of Calcineurin in Schwann Cells Does Not Affect Developmental Myelination, But Reduces Autophagy and Delays Myelin Clearance after Peripheral Nerve Injury.

Authors:  Chelsey B Reed; Luciana R Frick; Adam Weaver; Mariapaola Sidoli; Elizabeth Schlant; M Laura Feltri; Lawrence Wrabetz
Journal:  J Neurosci       Date:  2020-07-08       Impact factor: 6.167

8.  β4 integrin marks interstitial myogenic progenitor cells in adult murine skeletal muscle.

Authors:  Kalliopi Liadaki; Juan Carlos Casar; McKenzie Wessen; Eric S Luth; Susan Jun; Emanuela Gussoni; Louis M Kunkel
Journal:  J Histochem Cytochem       Date:  2012-01       Impact factor: 2.479

9.  TACE (ADAM17) inhibits Schwann cell myelination.

Authors:  Rosa La Marca; Federica Cerri; Keisuke Horiuchi; Angela Bachi; M Laura Feltri; Lawrence Wrabetz; Carl P Blobel; Angelo Quattrini; James L Salzer; Carla Taveggia
Journal:  Nat Neurosci       Date:  2011-06-12       Impact factor: 24.884

10.  Enhanced axonal neuregulin-1 type-III signaling ameliorates neurophysiology and hypomyelination in a Charcot-Marie-Tooth type 1B mouse model.

Authors:  Cristina Scapin; Cinzia Ferri; Emanuela Pettinato; Desiree Zambroni; Francesca Bianchi; Ubaldo Del Carro; Sophie Belin; Donatella Caruso; Nico Mitro; Marta Pellegatta; Carla Taveggia; Markus H Schwab; Klaus-Armin Nave; M Laura Feltri; Lawrence Wrabetz; Maurizio D'Antonio
Journal:  Hum Mol Genet       Date:  2019-03-15       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.